glycopyrrolate has been researched along with budesonide, formoterol fumarate drug combination in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeAngelis, K; Dorinsky, P; Ferguson, GT; Kerwin, EM; Mo, M | 1 |
| Fujimura, M; Hara, J; Ishii, N; Ishiura, Y; Kasahara, K; Nomura, S; Ohkura, N; Sawai, Y; Shimizu, T; Tamaki, T | 1 |
| Cheng, SH; Hsu, YJ; Huang, YL; Lai, JH; Lin, CW; Liou, JT; Pan, HY; Tsai, CL; Wang, MT | 1 |
| Effendi, WI; Emoto, N; Hazama, D; Katsurada, N; Kobayashi, K; Nagano, T; Nishimura, Y; Ryanto, GRT; Suraya, R; Tachihara, M; Yamamoto, M | 1 |
| Aceituno, S; Baloira, A; Calvo, A; Garin, N; Martínez, A; Prades, M; Torres, C; Touron, C; Trigueros, JA | 1 |
2 trial(s) available for glycopyrrolate and budesonide, formoterol fumarate drug combination
| Article | Year |
|---|---|
Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study.
Topics: Aged; Anti-Asthmatic Agents; Bone Density; Bronchodilator Agents; Budesonide, Formoterol Fumarate Drug Combination; Cataract; Double-Blind Method; Female; Glycopyrrolate; Humans; Intraocular Pressure; Lens, Crystalline; Male; Metered Dose Inhalers; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive | 2019 |
Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Aged, 80 and over; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome; Bronchodilator Agents; Budesonide, Formoterol Fumarate Drug Combination; Cross-Over Studies; Female; Glucocorticoids; Glycopyrrolate; Humans; Inspiratory Capacity; Japan; Lung; Male; Middle Aged; Muscarinic Antagonists; Pilot Projects; Recovery of Function; Time Factors; Treatment Outcome | 2020 |
3 other study(ies) available for glycopyrrolate and budesonide, formoterol fumarate drug combination
| Article | Year |
|---|---|
Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Beclomethasone; Benzyl Alcohols; Budesonide, Formoterol Fumarate Drug Combination; Chlorobenzenes; Cohort Studies; Comparative Effectiveness Research; Disease Progression; Drug Combinations; Female; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Glucocorticoids; Glycopyrrolate; Humans; Indans; Male; Muscarinic Antagonists; Pneumonia; Propensity Score; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Quinolones; Quinuclidines | 2021 |
Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation.
Topics: Animals; Bronchodilator Agents; Budesonide; Budesonide, Formoterol Fumarate Drug Combination; Emphysema; Endothelial Cells; Formoterol Fumarate; Fumarates; Glycopyrrolate; Hypertension, Pulmonary; Mice; NF-kappa B; Pancreatic Elastase; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema | 2022 |
Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain.
Topics: Bronchodilator Agents; Budesonide; Budesonide, Formoterol Fumarate Drug Combination; Cost-Benefit Analysis; Formoterol Fumarate; Fumarates; Glycopyrrolate; Humans; Pulmonary Disease, Chronic Obstructive; Spain | 2022 |